title: Cytokine profiles in relapsed multiple myeloma patients undergoing febrile reactions to lenalidomide.
authors: Yasuyoshi
authors: Y
authors: Morita
authors: Takahiro
authors: T
authors: Shimada
authors: Terufumi
authors: T
authors: Yamaguchi
authors: Shinya
authors: S
authors: Rai
authors: Chikara
authors: C
authors: Hirase
authors: Masakatsu
authors: M
authors: Emoto
authors: Kentaro
authors: K
authors: Serizawa
authors: Yasuhiro
authors: Y
authors: Taniguchi
authors: Mayuko
authors: M
authors: Ojima
authors: Yoichi
authors: Y
authors: Tatsumi
authors: Takashi
authors: T
authors: Ashida
authors: Itaru
authors: I
authors: Matsumura
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016207:Cytokines / Q000097:blood*; D005260:Female; D005334:Fever / Q000097:blood / Q000209:etiology*; D006801:Humans; D000077269:Lenalidomide; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood* / Q000150:complications* / Q000188:drug therapy; D012008:Recurrence; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D016207:Cytokines; D013792:Thalidomide; D000077269:Lenalidomide